Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by barcodewhizon Jan 05, 2016 12:38pm
444 Views
Post# 24430589

nice start to the year....

nice start to the year....

Sorry,  havent had the time to read the board,  so apologies if this has been posted.  The WSJ link has good institutional holding and other info.

https://quotes.wsj.com/CA/PLI/company-people

ALSO :  did this get posted ?  Combined with the Clulow / Thomvest insider buying... its no wonder we are seeing follow-on buying...  this is setting up very well technically to push to new highs.

ProMetic Life Sciences Climbs; BlackRock Funds Add to Position
2015-12-30 15:04:30.693 GMT


By Stefanie Batcho-Lino
(Bloomberg) -- ProMetic Life Sciences rises as much as 4.2%
to highest intraday (C$3.49) since Dec. 1, for ~10% gain over
four trading sessions.

* BlackRock fund added to position according to filing yday:
Bloomberg data
* PLI CN tops upper Bollinger Band; RSI to 67 vs 56 on Dec. 22
before advance over four trading sessions
* PLI CN has 7 buys, 0 holds, 0 sells, avg PT C$5.36:
Bloomberg data
* YTD performance: PLI CN +81% vs SPTSX -9.5%, STHLTH -16%;
PLI CN at least doubled its share price in past three years:
Bloomberg data
Bullboard Posts